Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 08, 2022

BUY
$72.62 - $79.98 $74,217 - $81,739
1,022 Added 18.37%
6,584 $507,000
Q4 2021

Feb 09, 2022

SELL
$53.63 - $62.52 $41,509 - $48,390
-774 Reduced 12.22%
5,562 $347,000
Q3 2021

Nov 12, 2021

SELL
$59.17 - $69.31 $227,331 - $266,289
-3,842 Reduced 37.75%
6,336 $375,000
Q2 2021

Aug 11, 2021

SELL
$61.91 - $67.42 $81,473 - $88,724
-1,316 Reduced 11.45%
10,178 $681,000
Q1 2021

May 11, 2021

SELL
$59.34 - $66.74 $47,709 - $53,658
-804 Reduced 6.54%
11,494 $726,000
Q4 2020

Feb 16, 2021

SELL
$57.74 - $65.43 $7.57 Million - $8.58 Million
-131,078 Reduced 91.42%
12,298 $763,000
Q3 2020

Nov 12, 2020

SELL
$57.43 - $63.64 $22,799 - $25,265
-397 Reduced 0.28%
143,376 $8.64 Million
Q1 2020

May 15, 2020

BUY
$46.4 - $67.43 $638,324 - $927,634
13,757 Added 10.58%
143,773 $8.01 Million
Q4 2019

Feb 14, 2020

BUY
$49.21 - $64.19 $1.61 Million - $2.1 Million
32,738 Added 33.65%
130,016 $8.35 Million
Q3 2019

Nov 13, 2019

BUY
$42.77 - $50.71 $1,496 - $1,774
35 Added 0.04%
97,278 $4.93 Million
Q2 2019

Aug 12, 2019

BUY
$44.62 - $49.34 $1.17 Million - $1.29 Million
26,132 Added 36.75%
97,243 $4.41 Million
Q1 2019

May 08, 2019

BUY
$45.12 - $53.8 $117,312 - $139,880
2,600 Added 3.8%
71,111 $3.39 Million
Q4 2018

Feb 07, 2019

BUY
$48.76 - $63.23 $682,640 - $885,220
14,000 Added 25.68%
68,511 $3.56 Million
Q3 2018

Oct 26, 2018

SELL
$55.19 - $62.25 $480,153 - $541,575
-8,700 Reduced 13.76%
54,511 $3.38 Million
Q2 2018

Aug 03, 2018

BUY
$50.53 - $62.98 $835,361 - $1.04 Million
16,532 Added 35.42%
63,211 $3.5 Million
Q4 2017

Feb 08, 2018

BUY
$59.94 - $65.35 $407,592 - $444,379
6,800 Added 17.05%
46,679 $2.86 Million
Q2 2017

Aug 15, 2017

SELL
N/A
-500 Reduced 1.24%
39,879 $2.22 Million
Q2 2017

Aug 14, 2017

BUY
N/A
40,379
40,379 $0

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $113B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Barings LLC Portfolio

Follow Barings LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Barings LLC, based on Form 13F filings with the SEC.

News

Stay updated on Barings LLC with notifications on news.